Brain and Body

Study Finds HPV Greatly Reduced in Teenage Girls Thanks to Vaccine

February 29, 2016 | Johannes Van Zijl

Nurse delivers a vaccination
Photo credit: CDC Public Health Image Library

Proves the vaccine has been a huge success!

The Human Papillomavirus (HPV) is a virus that affects the skin and moist membranes lining the organs of the body.  There are more than 100 different types of HPV and around 30 of those specifically affect the genital area of the body.  HPV can cause cervical cancer in women later in life if they contracted the virus at a young age.  

Since 2006, the Human Papilloma Virus (HPV) vaccine has been recommended to females 11 and 12 years of age and up until the age of 26, given they were not previously vaccinated for HPV. The vaccine helps by forming an immune barrier to prevent any infection by HPV and thus, reducing the risk of developing cervical cancer later in life.

SEE ALSO: This Biotech Company Developed Two Potential Vaccines for the Zika Virus

Newly released data from the Centers of Disease Control and Prevention suggests that the HPV vaccine has greatly reduced the prevalence of the virus in 64 percent of teenage girls and 34 percent of women in their early 20s, who were vaccinated during the recommended ages.  The study was recently published in the Journal of Pediatrics, however, it does not include any data on boys who received the HPV vaccine.

Estimates suggest that roughly 14 million Americans become infected with HPV every year, with most being able to fight off the viral infection. Unfortunately, some strains of the virus persist for longer periods of time in the affected individual, which can sometimes lead to several forms of cancer, including throat, anal, penile and cervical.

Hot Topics

Facebook comments